Ben Chlebina

Foment Bio is a clinical-stage biotechnology company developing non-viral, off-the-shelf, gene-based products that activate natural healing cascades to repair tissue and restore function. The company’s pipeline consists of products that drive transient in vivo production of regenerative exosomes able to promote new blood vessel growth, prevent cell death, reduce scar formation, and resolve tissue inflammation.